This study's results contribute to the growing body of knowledge on the role of IFN signaling in bone diseases and pave the way for future research into the development of targeted therapies for OPLL.

The authors suggest that inhibition of IFN-γ signaling could provide a novel approach for the concomitant prevention of inflammation and bone loss in common osteoporotic conditions, including ...